A Validated Prognostic Biomarker Score for Adult Patients with Nonmetastatic Soft Tissue Sarcomas of the Trunk and Extremities.

Abstract:

BACKGROUND:The prognostic value of serum biomarkers in soft tissue sarcoma (STS) is limited, and its clinical applicability is compromised by a common inability to adjust for important confounders. The aim of this study was to determine the prognostic value of pretreatment biomarkers on disease-specific survival (DSS) adjusted for confounders. METHODS:The study included 818 patients with localized STS. Pretreatment levels of albumin, C-reactive protein, hemoglobin, neutrophils, and lymphocytes were tested individually and combined in prognostic scores: neutrophil/lymphocyte ratio (NLR), Glasgow Prognostic Score (GPS), and Aarhus Composite Biomarker Score (ACBS) which includes all five biomarkers. Patients were randomly split into a test cohort and a validation cohort. The prognostic value of biomarkers on DSS was estimated using crude and adjusted Cox proportional hazard models. The different biomarker scores were compared using Akaike's information criteria. RESULTS:In the test cohort of 403 patients, all biomarkers except lymphocyte count were significant prognostic factors for DSS also after adjusting for confounders. NLR, GPS, and ACBS were independently associated with decreased survival; however, ACBS was significantly superior to NLR (P=.02) and GPS (P=.002). These findings were validated in the randomly assigned validation cohort of 415 patients. In the pooled data of 818 patients, the ACBS performed better than GPS and NLR. ACBS 2 was independently associated with decreased DSS compared to ACBS 0, hazard ratio 2.3[95% confidence interval: 1.5-3.5], P<.001. CONCLUSION:Patients with abnormal values in more than one serum biomarkers had a significant additional risk of dying compared to patients with only one abnormal value. ACBS was validated as an independent prognostic factor that is superior to both NLR and GPS.

journal_name

Transl Oncol

journal_title

Translational oncology

authors

Maretty-Kongstad K,Aggerholm-Pedersen N,Keller J,Safwat A

doi

10.1016/j.tranon.2017.09.002

subject

Has Abstract

pub_date

2017-12-01 00:00:00

pages

942-948

issue

6

issn

1936-5233

pii

S1936-5233(17)30301-7

journal_volume

10

pub_type

杂志文章
  • Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell Carcinoma.

    abstract::The accumulation of lipids is a hallmark of human clear cell renal cell carcinoma (ccRCC). Advanced ccRCC tumors frequently show increased lipid biosynthesis, but the regulation of lipid metabolism in early stage ccRCC tumors has not been studied. Here, we performed combined transcriptomics and metabolomics on a previ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2019.10.015

    authors: van der Mijn JC,Fu L,Khani F,Zhang T,Molina AM,Barbieri CE,Chen Q,Gross SS,Gudas LJ,Nanus DM

    更新日期:2020-02-01 00:00:00

  • Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy.

    abstract::Insufficient delivery of systemically administered anticancer drugs to tumors can compromise therapeutic efficacy and develop drug delivery-based therapeutic resistance. Nanotherapeutics such as PEGylated liposomal doxorubicin (PLD) are designed to preferentially accumulate in tumors utilizing enhanced permeation and ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2019.05.011

    authors: Kai M,Ziemys A,Liu YT,Kojic M,Ferrari M,Yokoi K

    更新日期:2019-09-01 00:00:00

  • Three paths to better tyrosine kinase inhibition behind the blood-brain barrier in treating chronic myelogenous leukemia and glioblastoma with imatinib.

    abstract::Chronic myelogenous leukemia (CML) can be controlled for years with the tyrosine kinase inhibitor imatinib but because imatinib poorly penetrates the blood-brain barrier (BBB), on occasion, the CML clone will thrive and evolve to an accelerated phase in the resulting imatinib sanctuary within the central nervous syste...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.09280

    authors: Kast RE,Focosi D

    更新日期:2010-02-01 00:00:00

  • Mutations, Differential Gene Expression, and Chimeric Transcripts in Esophageal Squamous Cell Carcinoma Show High Heterogeneity.

    abstract::Esophageal squamous cell carcinoma (ESCC) is a frequent and lethal neoplasia. As recent advances in targeted therapy have not improved ESCC prognosis, characterization of molecular alterations associated to this tumor is of foremost relevance. In this study, we analyze, for the first time, the complete genomic profile...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.08.002

    authors: Souza-Santos PT,Soares Lima SC,Nicolau-Neto P,Boroni M,Meireles Da Costa N,Brewer L,Menezes AN,Furtado C,Moreira MAM,Seuanez HN,de Almeida Simão T,Ribeiro Pinto LF

    更新日期:2018-12-01 00:00:00

  • Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.

    abstract::Peritoneal carcinomatosis (PC) of colorectal origin is associated with a poor prognosis. However, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy is available for a selected group of PC patients, which significantly increases overall survival rates up to 30%. As a consequence, there is su...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.10220

    authors: van Oosten M,Crane LM,Bart J,van Leeuwen FW,van Dam GM

    更新日期:2011-04-01 00:00:00

  • MicroRNA-506-3p increases the response to PARP inhibitors and cisplatin by targeting EZH2/β-catenin in serous ovarian cancers.

    abstract::Chemo-resistance is an important barrier to effective treatment of ovarian cancer. Poly (ADP-ribose) polymerase (PARP) inhibitors are currently promising targeted drugs used to treat BRCA-mutant ovarian cancer. Ovarian cancer patients with BRCA 1/2 mutations appear to benefit better from PARP inhibitors and chemothera...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100987

    authors: Sun Y,Wu J,Dong X,Zhang J,Meng C,Liu G

    更新日期:2021-02-01 00:00:00

  • Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.

    abstract::MicroRNAs are endogenous posttranscriptional modulators that negatively control the expression of their target genes and play an important role in the development and progression of many malignancies, including colorectal carcinoma. In particular, expression of microRNA-21 (miR-21) is greatly increased in chemotherapy...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.12397

    authors: Yu Y,Sarkar FH,Majumdar AP

    更新日期:2013-04-01 00:00:00

  • Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer.

    abstract:BACKGROUND:An elevated preoperative C-reactive protein/albumin (CRP/Alb) ratio has been reported to be associated with a poor prognosis for hepatocellular carcinoma. The aim of the present study was to investigate the prognostic value of the preoperative CRP/Alb ratio and compare it with other systemic inflammatory res...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2015.06.006

    authors: Liu X,Sun X,Liu J,Kong P,Chen S,Zhan Y,Xu D

    更新日期:2015-08-01 00:00:00

  • Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma.

    abstract::Receptor tyrosine kinases (RTKs) are membrane receptors that play a vital role in various biological processes, in particular, cell survival, cell proliferation, and cell differentiation. These cellular processes are composed of multitiered signaling cascades of kinases starting from ligand binding to extracellular do...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.08.005

    authors: Chaiyawat P,Klangjorhor J,Settakorn J,Champattanachai V,Phanphaisarn A,Teeyakasem P,Svasti J,Pruksakorn D

    更新日期:2017-10-01 00:00:00

  • Contrast Enhancement on Cone-Beam Breast-CT for Discrimination of Breast Cancer Immunohistochemical Subtypes.

    abstract:PURPOSE:To evaluate whether contrast enhancement on cone-beam breast-CT (CBBCT) could aid in discrimination of breast cancer subtypes and receptor status. METHODS:This study included female patients age >40 years with malignant breast lesions identified on contrast-enhanced CBBCT. Contrast enhancement of malignant bre...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.08.010

    authors: Uhlig J,Fischer U,von Fintel E,Stahnke V,Perske C,Lotz J,Wienbeck S

    更新日期:2017-12-01 00:00:00

  • The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model.

    abstract::Metastatic disease still lacks effective treatments, and remains the primary cause of cancer mortality. Therefore, there is a critical need to develop better strategies to inhibit metastatic cancer. The Rho family GTPase Rac is an ideal target for anti-metastatic cancer therapy, because Rac is a key molecular switch t...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2014.07.004

    authors: Castillo-Pichardo L,Humphries-Bickley T,De La Parra C,Forestier-Roman I,Martinez-Ferrer M,Hernandez E,Vlaar C,Ferrer-Acosta Y,Washington AV,Cubano LA,Rodriguez-Orengo J,Dharmawardhane S

    更新日期:2014-10-24 00:00:00

  • Microsatellite Alterations and Protein Expression of 5 Major Tumor Suppressor Genes in Gastric Adenocarcinomas.

    abstract:PURPOSE:In gastric adenocarcinoma (GC), the major tumor suppressor genes (TSGs) such as p16, PTEN, Rb, E-cadherin, and p53, may play important roles in various regulatory pathways and in tumor suppression. This study evaluated the loss of heterozygosity (LOH) of microsatellite and protein expression of 5 TSGs and the r...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.10.007

    authors: Choi WH,Lee S,Cho S

    更新日期:2018-02-01 00:00:00

  • Chromosomal Alterations and Gene Expression Changes Associated with the Progression of Leukoplakia to Advanced Gingivobuccal Cancer.

    abstract::We present an integrative genome-wide analysis that can be used to predict the risk of progression from leukoplakia to oral squamous cell carcinoma (OSCC) arising in the gingivobuccal complex (GBC). We find that the genomic and transcriptomic profiles of leukoplakia resemble those observed in later stages of OSCC and ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.03.008

    authors: Bhosale PG,Cristea S,Ambatipudi S,Desai RS,Kumar R,Patil A,Kane S,Borges AM,Schäffer AA,Beerenwinkel N,Mahimkar MB

    更新日期:2017-06-01 00:00:00

  • Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?

    abstract::Programmed cell death-ligand 2 (PD-L2) is one of the two ligands of the programmed cell death-1 (PD-1) receptor, an inhibitory protein mainly expressed on activated immune cells that is targeted in the clinic, with successful and remarkable results. The PD-1/PD-Ls axis was shown to be one of the most relevant immunosu...

    journal_title:Translational oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.tranon.2020.100811

    authors: Solinas C,Aiello M,Rozali E,Lambertini M,Willard-Gallo K,Migliori E

    更新日期:2020-10-01 00:00:00

  • Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer.

    abstract:OBJECTIVE:This study investigated the feasibility of using malignant pleural effusion (MPE) supernatant and paired cell blocks (precipitate) for gene profiling in patients with non-small cell lung cancer (NSCLC) using next-generation sequencing (NGS) technique. METHODS:Stage IV non-squamous NSCLC patients with MPE wer...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100784

    authors: Li J,Li X,Wang W,Shao Y,Zhang Y,Song Z

    更新日期:2020-08-01 00:00:00

  • Pathological Pattern of Intrahepatic HBV in HCC is Phenocopied by PDX-Derived Mice: a Novel Model for Antiviral Treatment.

    abstract:BACKGROUND:Hepatitis B virus (HBV) is one of the most prominent risk factors for hepatocellular carcinoma (HCC) development and virus-mediated cases represents more than 80% of HCC in East Asia, where it is endemic. Currently, the HBV status of pathological HCC is not fully clarified, especially by comparison to nontum...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2019.05.006

    authors: Liu J,Chen S,Zou Z,Tan D,Liu X,Wang X

    更新日期:2019-09-01 00:00:00

  • Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer.

    abstract::Tumor hypoxia contributes to therapy resistance and metastatic progression of locally advanced rectal cancer (LARC). We postulated that the tumor mitochondrial metabolism, manifested by reactive oxygen species (ROS) and mitochondrial DNA (mtDNA) damage, reflects how hypoxic conditions connect to cancer-induced systemi...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.09.010

    authors: Bousquet PA,Meltzer S,Sønstevold L,Esbensen Y,Dueland S,Flatmark K,Sitter B,Bathen TF,Seierstad T,Redalen KR,Eide L,Ree AH

    更新日期:2019-01-01 00:00:00

  • Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status.

    abstract::Glioblastoma (GBM) with oligodendroglioma component (GBMO) is a newly described GBM subtype in the 2007 World Health Organization classification. However, its biological and genetic characteristics are largely unknown. We investigated the clinicopathological and molecular features of 34 GBMOs and compared the survival...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2014.10.002

    authors: Myung JK,Cho HJ,Kim H,Park CK,Lee SH,Choi SH,Park P,Yoon JM,Park SH

    更新日期:2014-12-01 00:00:00

  • Multi-Spectral Fluorescence Imaging of Colon Dysplasia InVivo Using a Multi-Spectral Endoscopy System.

    abstract:BACKGROUND AND STUDY AIM:To develop a molecular imaging endoscopic system that eliminates tissue autofluorescence and distinguishes multiple fluorescent markers specifically on the cancerous lesions. METHODS:Newly developed multi-spectral fluorescence endoscope device has the potential to eliminate signal interference...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.10.006

    authors: Bae SM,Bae DJ,Do EJ,Oh G,Yoo SW,Lee GJ,Chae JS,Yun Y,Kim S,Kim KH,Chung E,Kim JK,Hwang SW,Park SH,Yang DH,Ye BD,Byeon JS,Yang SK,Joo J,Kim SY,Myung SJ

    更新日期:2019-02-01 00:00:00

  • Strategies for high-resolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopy.

    abstract::Ovarian cancer remains the most frequently lethal of the gynecologic cancers owing to the late detection of this disease. Here, by using human specimens and three mouse models of ovarian cancer, we tested the feasibility of nonlinear imaging approaches, the multiphoton microscopy (MPM) and second harmonic generation (...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.09310

    authors: Williams RM,Flesken-Nikitin A,Ellenson LH,Connolly DC,Hamilton TC,Nikitin AY,Zipfel WR

    更新日期:2010-06-01 00:00:00

  • Predicting Treatment Response of Breast Cancer to Neoadjuvant Chemotherapy Using Ultrasound-Guided Diffuse Optical Tomography.

    abstract:PURPOSE:To prospectively investigate ultrasound-guided diffuse optical tomography (US-guided DOT) in predicting breast cancer response to neoadjuvant chemotherapy (NAC). MATERIALS AND METHODS:Eighty-eight breast cancer patients, with a total of 93 lesions, were included in our study. Pre- and post-last chemotherapy, s...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.10.011

    authors: Zhi W,Liu G,Chang C,Miao A,Zhu X,Xie L,Zhou J

    更新日期:2018-02-01 00:00:00

  • Limitations of Anti-Angiogenic Treatment of Tumors.

    abstract::Clinical trials using anti-vascular endothelial growth factor /(VEGF) molecules induce a modest improvement in overall survival, measurable in weeks to just a few months, and tumors respond differently to these agents. In this review article, we have exposed some tumor characteristics and processes that may impair the...

    journal_title:Translational oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.tranon.2019.04.022

    authors: Ribatti D,Annese T,Ruggieri S,Tamma R,Crivellato E

    更新日期:2019-07-01 00:00:00

  • Comparison of a Concurrent Fluorouracil-Based Regimen and a Taxane-Based Regimen Combined with Radiotherapy in Elderly Patients with Esophageal Squamous Cell Carcinoma.

    abstract::Elderly patients with esophageal carcinoma may benefit from concurrent chemoradiotherapy (CCRT). However, the optimal concurrent chemotherapy regimen has not been determined. The aim of our study was to assess the efficiency and tolerance of treatment with a concurrent 5-fluorouracil (5-Fu)-based regimen and a taxane-...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2019.12.008

    authors: Huang C,Huang D,Zhu Y,Xie G,Wang H,Shi J,Jia B,Yuan Y,Zhang W

    更新日期:2020-03-01 00:00:00

  • Suitability of surgical tumor tissues, biopsy, or cytology samples for epidermal growth factor receptor mutation testing in non-small cell lung carcinoma based on chinese population.

    abstract:BACKGROUND:Epidermal growth factor receptor (EGFR) mutation status is crucial in treatment selection for non-small cell lung cancer (NSCLC) patients; however, the detection materials' availability remains challenging in clinical practice. In this study, we collected surgical resection tissues, lymph node biopsy, and cy...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2014.10.008

    authors: Han X,Zhang Z,Wu D,Shen Y,Wang S,Wang L,Liu Y,Yang S,Hu X,Feng Y,Sun Y,Shi Y

    更新日期:2014-12-01 00:00:00

  • Smoking-Induced SLPI Expression Hinders HPV Infections Also in Squamous Cell Carcinomas of the Vulva.

    abstract::In HNSCC, protein- and mRNA-expression of the antileukoproteinase SLPI are significantly inverse correlated with HPV-infection suggesting that elevated expression of SLPI protects against HPV-infections. Moreover, SLPI-expression is up-regulated in HNSCC-patients reporting a smoking habit. Here, we investigate the des...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.09.004

    authors: Quabius ES,Loehr J,Haaser D,Günther V,Maass N,Röcken C,Mathiak M,Alkatout I,Hoffmann M

    更新日期:2019-01-01 00:00:00

  • EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo.

    abstract::ErbB-3 (HER-3) receptor is involved in tumor progression and resistance to therapy. Development of specific inhibitors impairing the activity of ErbB-3 is an attractive tool for cancer therapeutics. MP-RM-1, a murine monoclonal antibody targeting human ErbB-3, has shown anticancer activity in preclinical models. With ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.13475

    authors: Sala G,Rapposelli IG,Ghasemi R,Piccolo E,Traini S,Capone E,Rossi C,Pelliccia A,Di Risio A,D'Egidio M,Tinari N,Muraro R,Iacobelli S,Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO).

    更新日期:2013-12-01 00:00:00

  • TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer.

    abstract::This study aimed to identify novel prognostic biomarker for advanced renal cell carcinoma (RCC) patients treated with anti-PD-1 therapy, using quantitative multi-immunofluorescence (IF) analysis of tumor immunity. Twenty-five consecutive patients who had metastatic or unresectable RCC treated with anti-PD-1 therapy we...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100918

    authors: Kato R,Jinnouchi N,Tuyukubo T,Ikarashi D,Matsuura T,Maekawa S,Kato Y,Kanehira M,Takata R,Ishida K,Obara W

    更新日期:2021-01-01 00:00:00

  • Inhibitor of DNA Binding 2 Inhibits Epithelial-Mesenchymal Transition via Up-Regulation of Notch3 in Breast Cancer.

    abstract::Breast cancer is the second leading cause of cancer death in women worldwide. Incurable metastatic breast disease presents a major clinical challenge and is the main cause of breast cancer-related death. The epithelial-mesenchymal transition (EMT) is a critical early promoter of metastasis. In the present study, we id...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.07.015

    authors: Wen XF,Chen M,Wu Y,Chen MN,Glogowska A,Klonisch T,Zhang GJ

    更新日期:2018-10-01 00:00:00

  • Development of near-infrared imaging agents for detection of junction adhesion molecule-A protein.

    abstract:INTRODUCTION:Prostate and breast cancer are the most prevalent primary malignant human tumors globally. Prostatectomy and breast conservative surgery remain the most common definitive treatment option for the >500,000 men and women newly diagnosed with localized prostate and breast cancer each year only in the US. Morp...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.101007

    authors: Walker E,Turaga SM,Wang X,Gopalakrishnan R,Shukla S,Basilion JP,Lathia JD

    更新日期:2021-01-06 00:00:00

  • Hydrogen Sulfide Demonstrates Promising Antitumor Efficacy in Gastric Carcinoma by Targeting MGAT5.

    abstract::Mannosyl (alpha-1,6-)-Glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase (MGAT5) is exclusively expressed in gastric carcinoma, and plays an essential role in cancer progression, but no targeted drug is available so far. The potential anti-cancer effect of Hydrogen Sulfide (H2S), has not been widely recognized. It...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.04.008

    authors: Wang R,Fan Q,Zhang J,Zhang X,Kang Y,Wang Z

    更新日期:2018-08-01 00:00:00